SCHEMBL4757285

SCHEMBL4757285

Cc1ccc(C(=O)Nc2nc(S(C)(=O)=O)cs2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 0.64
NPC1 O15118 6/20 0.64
ALDH1A1 P00352 3/20 0.64
KMT2A Q03164 3/20 0.64
MEN1 O00255 2/20 0.64
GAA P10253 1/20 0.64
MAPT P10636 3/20 0.60
ADORA3 P0DMS8 2/20 0.55
SMN1; SMN2 Q16637 7/20 0.52
KDM4E B2RXH2 2/20 0.52
LMNA P02545 2/20 0.52
POLB P06746 1/20 0.52
HPGD P15428 1/20 0.52
RECQL P46063 1/20 0.52
TDP1 Q9NUW8 1/20 0.49
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
HTT P42858 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703145 0.89 RAB9A (0.60) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4757970 0.87 NPC1 (0.65) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4757291 0.84 NPC1 (0.49) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4757037 0.84 GCK (0.58) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL3692973 0.83 RAB9A (0.54) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL705314 0.83 RAB9A (0.57) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4757279 0.83 RRM1 (0.62) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4757366 0.82 NPC1 (0.53) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4757096 0.81 NPC1 (0.48) RAB9ANPC1ALDH1A1KMT2AMEN1
SCHEMBL4756405 0.81 NPC1 (0.50) RAB9ANPC1ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC RAB9A 1694/4885NPC1 585/4885ALDH1A1 1605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.